Kornitzer Capital Management Inc Bristol Myers Squibb CO Transaction History

Kornitzer Capital Management Inc

  • $4.91 Billion
  • Q4 2024

A detailed history of Kornitzer Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 306,517 shares of BMY stock, worth $17.6 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
306,517
Previous 291,387 5.19%
Holding current value
$17.6 Million
Previous $15.1 Million 14.97%
% of portfolio
0.35%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$51.92 - $59.94 $785,549 - $906,892
15,130 Added 5.19%
306,517 $17.3 Million
Q3 2024

Oct 31, 2024
BUY
$39.66 - $51.75 $41,246 - $53,820
1,040 Added 0.36%
291,387 $15.1 Million
Q2 2024

Aug 02, 2024
BUY
$40.25 - $52.99 $352,912 - $464,616
8,768 Added 3.11%
290,347 $12.1 Million
Q1 2024

May 01, 2024
BUY
$47.98 - $54.4 $644,659 - $730,918
13,436 Added 5.01%
281,579 $15.3 Million
Q4 2023

Jan 31, 2024
BUY
$48.48 - $57.85 $188,296 - $224,689
3,884 Added 1.47%
268,143 $13.8 Million
Q3 2023

Oct 31, 2023
SELL
$57.89 - $64.73 $18,235 - $20,389
-315 Reduced 0.12%
264,259 $15.3 Million
Q2 2023

Aug 01, 2023
BUY
$63.71 - $70.74 $509 - $565
8 Added 0.0%
264,574 $16.9 Million
Q1 2023

May 09, 2023
SELL
$65.71 - $74.53 $11,039 - $12,521
-168 Reduced 0.06%
264,566 $18.3 Million
Q4 2022

Feb 02, 2023
SELL
$68.48 - $81.09 $154,764 - $183,263
-2,260 Reduced 0.85%
264,734 $19 Million
Q3 2022

Nov 03, 2022
SELL
$0.13 - $76.84 $546 - $323,112
-4,205 Reduced 1.55%
266,994 $19 Million
Q2 2022

Aug 03, 2022
SELL
$72.62 - $79.98 $248,505 - $273,691
-3,422 Reduced 1.25%
271,199 $20.9 Million
Q1 2022

Apr 27, 2022
SELL
$61.48 - $73.72 $61,172 - $73,351
-995 Reduced 0.36%
274,621 $20.1 Million
Q4 2021

Feb 01, 2022
BUY
$53.63 - $62.52 $221,062 - $257,707
4,122 Added 1.52%
275,616 $17.2 Million
Q3 2021

Nov 03, 2021
SELL
$59.17 - $69.31 $155,972 - $182,701
-2,636 Reduced 0.96%
271,494 $16.1 Million
Q2 2021

Jul 30, 2021
SELL
$61.91 - $67.42 $250,735 - $273,051
-4,050 Reduced 1.46%
274,130 $18.3 Million
Q1 2021

Apr 30, 2021
BUY
$59.34 - $66.74 $1.21 Million - $1.37 Million
20,455 Added 7.94%
278,180 $17.6 Million
Q4 2020

Jan 29, 2021
SELL
$57.74 - $65.43 $833,765 - $944,809
-14,440 Reduced 5.31%
257,725 $16 Million
Q3 2020

Oct 30, 2020
SELL
$57.43 - $63.64 $71,213 - $78,913
-1,240 Reduced 0.45%
272,165 $16.4 Million
Q2 2020

Aug 03, 2020
SELL
$54.82 - $64.09 $159,252 - $186,181
-2,905 Reduced 1.05%
273,405 $16.1 Million
Q1 2020

Apr 30, 2020
SELL
$46.4 - $67.43 $396,024 - $575,515
-8,535 Reduced 3.0%
276,310 $15.4 Million
Q4 2019

Jan 31, 2020
SELL
$49.21 - $64.19 $92,514 - $120,677
-1,880 Reduced 0.66%
284,845 $18.3 Million
Q3 2019

Nov 04, 2019
BUY
$42.77 - $50.71 $459,349 - $544,625
10,740 Added 3.89%
286,725 $14.5 Million
Q2 2019

Jul 31, 2019
BUY
$44.62 - $49.34 $1.41 Million - $1.56 Million
31,615 Added 12.94%
275,985 $12.5 Million
Q1 2019

May 01, 2019
BUY
$45.12 - $53.8 $1.2 Million - $1.43 Million
26,575 Added 12.2%
244,370 $11.7 Million
Q4 2018

Jan 31, 2019
SELL
$48.76 - $63.23 $22,429 - $29,085
-460 Reduced 0.21%
217,795 $11.3 Million
Q3 2018

Nov 13, 2018
BUY
$55.19 - $62.25 $169,709 - $191,418
3,075 Added 1.43%
218,255 $13.5 Million
Q2 2018

Aug 02, 2018
BUY
$50.53 - $62.98 $699,335 - $871,643
13,840 Added 6.87%
215,180 $11.9 Million
Q1 2018

Apr 30, 2018
BUY
$59.92 - $68.98 $117,742 - $135,545
1,965 Added 0.99%
201,340 $12.7 Million
Q4 2017

Jan 31, 2018
SELL
$59.94 - $65.35 $285,913 - $311,719
-4,770 Reduced 2.34%
199,375 $12.2 Million
Q3 2017

Oct 31, 2017
BUY
$55.23 - $63.74 $11.3 Million - $13 Million
204,145
204,145 $13 Million

Others Institutions Holding BMY

# of Institutions
2,753
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email